Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra
24/7 Wall St
Friday, October 24, 2014 - 8:38am
tags:
Pfizer, stock buyback
High Drug Prices Could Increase Industry Innovation
Forbes
Friday, October 24, 2014 - 8:37am
tags:
innovation, drug pricing
Pfizer stock buyback dims prospects of AstraZeneca bid
Seeking Alpha
Friday, October 24, 2014 - 8:04am
tags:
Pfizer, AstraZeneca, M&A, stock buyback
Actavis CEO Saunders Has $70 Billion in Deals to Choose From
Bloomberg
Friday, October 24, 2014 - 8:02am
tags:
Actavis, M&A, Brent Saunders, Allergan, Pfizer, Omega Pharma, Salix
Bristol-Myers beats 3Q earnings and revenue expectations
Yahoo/AP
Friday, October 24, 2014 - 7:45am
tags:
Bristol-Myers Squibb, earnings
Why Earnings Season Could Be Great for Ligand
Yahoo/Zacks.com
Friday, October 24, 2014 - 7:36am
tags:
earnings, Ligand
Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?"
Forbes
Friday, October 24, 2014 - 7:35am
tags:
vaccines, ebola virus, R&D, clinical trials, GSK
Jilted Shire raises guidance again after Q3 earnings jump
Yahoo/Reuters
Friday, October 24, 2014 - 7:32am
tags:
Shire, earnings
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Friday, October 24, 2014 - 7:31am
tags:
AstraZeneca, ovarian cancer, Europe, Lynparza, olaparib
In biotech's boardrooms, there are 10 men for every one woman, report says
Fierce Biotech
Thursday, October 23, 2014 - 5:43pm
tags:
biotech
Zimmer Holdings, Inc. Stays Ahead with a Healthy Third Quarter
Motley Fool
Thursday, October 23, 2014 - 5:42pm
tags:
Zimmer, earnings
Will Celgene Become the Next $100 Billion Biotech Stock?
24/7 Wall St
Thursday, October 23, 2014 - 5:34pm
tags:
Celgene
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
Bloomberg
Thursday, October 23, 2014 - 5:28pm
tags:
JNJ, Pinnacle Hip, devices, hip implants
Eli Lilly/Boehringer's Diabetes Drug Under FDA Review
Yahoo/Zacks.com
Thursday, October 23, 2014 - 5:27pm
tags:
Eli Lilly, Boehringer Ingelheim, diabetes, FDA, Jardiance, metformin
Pfizer Announces It Will Buy Back $11 Billion in Shares
Bloomberg
Thursday, October 23, 2014 - 5:26pm
tags:
Pfizer, share repurchase
GSK restructures, as respiratory disappoints
Medical Marketing and Media
Thursday, October 23, 2014 - 9:52am
tags:
GSK
Celgene 3rd-quarter profit jumps 37 pct, tops forecast
Yahoo/Reuters
Thursday, October 23, 2014 - 9:39am
tags:
Celgene, earnings
Alexion Pharma quarterly adj profit beats, raises forecast again
Yahoo/Reuters
Thursday, October 23, 2014 - 9:38am
tags:
Alexion, earnings
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised
Yahoo/Zacks.com
Thursday, October 23, 2014 - 9:37am
tags:
CR Bard, earnings, devices
Boehringer revs up Ofev sales force, support services to rival Roche's Esbriet in IPF
Fierce Pharma Marketing
Thursday, October 23, 2014 - 8:41am
tags:
Boehringer Ingelheim, drug reps, Ofev, Roche, Esbriet, IPF

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.